Assessment of platelet growth factors in supernatants from rehydrated freeze-dried equine platelets and their effects on fibroblasts in vitro

American Journal of Veterinary Research

Volumn 69, Issue 11, 2008, Pages 1512-1519

  Tablin, Fern ^a   Walker, Naomi J ^a   Hogle, Sara E ^a   Pratt, Suzanne M ^b   Norris, Jeffrey W ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b PURDUE UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

COLLAGEN GEL; MACROGOL 4000; PLATELET DERIVED GROWTH FACTOR; PLATELET DERIVED GROWTH FACTOR BB; THROMBIN; THROMBOCYTE ACTIVATING FACTOR; TRANSFORMING GROWTH FACTOR BETA1; TREHALOSE;

ANIMAL CELL; ARTICLE; BLOOD SAMPLING; CELL ASSAY; CELL MIGRATION; CELL PROLIFERATION; CELL STIMULATION; CONCENTRATION (PARAMETERS); CONTROLLED STUDY; CULTURE MEDIUM; ENZYME LINKED IMMUNOSORBENT ASSAY; FETAL BOVINE SERUM; FIBROBLAST; FREEZE DRYING; HORSE; IN VITRO STUDY; NONHUMAN; REHYDRATION; SUPERNATANT; THROMBOCYTE;

ANIMALS; BLOOD PLATELETS; CELL MOVEMENT; CELL PROLIFERATION; CENTRIFUGATION; ENZYME-LINKED IMMUNOSORBENT ASSAY; FIBROBLASTS; FREEZE DRYING; HORSES; PLATELET-DERIVED GROWTH FACTOR; TRANSFORMING GROWTH FACTOR BETA1;

ANIMALIA; BOVINAE; EQUIDAE;

EID: 56749175131     PISSN: 00029645     EISSN: None     Source Type: Journal    
DOI: 10.2460/ajvr.69.11.1512     Document Type: Article

References (38)

1. Bertone AL. Second intention healing. Vet Clin North Am Equine Pract 1989;5:539-550.
2. Walton GS, Neal PA. Observations on wound healing in the horse: the role of wound contraction. Equine Vet J 1972;4:93-97.
3. Wilmink JM, van Weeren PR, Stolk PW, et al. Differences in second-imention wound healing between horses and ponies: histological aspects. Equine Vet J 1999;31:61-67.
4. Chvapil M, Pfister T, Escalada T, et al. Dynamics of the healing of skin wounds in the horse as compared with the rat. Exp Mol Pathol 1979;30:349-359.
5. Jacobs KA, Leach DH, Fretz PB, et al. Comparative aspects of the healing of excisional wounds on the leg and body of horses. Vet Surg 1984;13:83-90.
6. Cochrane CA. Models in vivo of wound healing in the horse and the role of growth factors. Vet Dermatol 1997;8:259-272.
7. Lepault E, Celeste C, Dore M, et al. Comparative study on microvascular occlusion and apoptosis in body and limb wounds in the horse. Wound Rep Reg 2005;13:520-529.
8. Crovetti G, Martinelli G, Issi M, et al. Platelet gel for healing cutaneous chronic wounds. Transfus Apheresis Sci 2004;30:145-151.
9. Dart AJ, Cries L, Jeffcott LB, et al. The effect of equine recombinant growth hormone on second intention wound healing in horses. Vet Surg 2002;31:314-319.
10. Wilson DA, Adelstein EH, Keegan KG, et al. In vitro and in vivo effects of activated macrophage supernatant on distal limb wounds of ponies. Am J Vet Res 1996;57:1220-1224.
11. Harrison P, Cramer EM. Platelet alpha-granules. Blood Rev 1993;7:52-62.
12. Wilmink JM, Nederbragt H, van Weeren PR, et al. Differences in wound contraction between horses and ponies: the in vitro contraction capacity of fibroblasts. Equine Vet J 2001;5:499-505.
13. Van den Boom R, Wilmink JM, Okane S, et al. Transforming growth factor-β levels during second-intention wound healing are related to the different course of wound contraction in horses and ponies. Wound Repair Regen 2002;10:188-194.
14. Miller CB, Wilson DA, Keegan KG, et al. Growth characteristics of fibroblasts isolated from the trunk and distal aspect of the limb of horses and ponies. Vet Surg 2000;29:1-7.
15. Henderson JL, Cupp CL, Ross EV, et al. The effects of autologous platelet gel on wound healing. Ear Nose Throat J 2003;82:598-602.
16. Mazzucco L, Medici D, Serr M, et al. The use of autologous platelet gel to treat difficult-to-heal wounds: a pilot study. Transfusion 2004;44:1013-1018.
17. Carter CA, Jolly DG, Worden CE Sr, et al. Platelet-rich plasma gel promotes differentiation and regeneration during equine wound healing. Exp Mol Pathol 2003;74:244-255.
18. Crowe JH, Tablin F, Wolkers W, et al. Stabilization of membranes in human platelets freeze-dried with trehalose. Chem Phys Lipids 2003;122:41-45.
19. Norris JW, Pratt SM, Auh J-H, et al. Investigation of a novel, heritable bleeding diathesis of Thoroughbred horses and development of a screening assay. J Vet Intern Med 2006;20:1450-1456.
20. Desjargins I, Theoret CL, Joubert P, et al. Comparison of TGF-β1 concentrations in bronchoalveolar fluid of horses affected with heaves and of normal controls. J Vet Immunopathol 2004;101:133-141.
21. Schnabel LV, Mohammed HO, Miller BJ, et al. Platelet rich plasma (PRP) enhances anabolic gene expression patterns in flexor digitorum superficialis tendons. J Orthop Res 2006;25:230-240.
22. Bell E, Ivarsson B, Merrill C. Production of a tissue-like structure by contraction of collagen lattices by human fibroblasts of different proliferative potential in vitro. Proc Natl Acad Sci U S A 1979;76:1274-1278.
23. Grinnell F, Lamke CR. Reorganization of hydrated collagen lattices by human skin fibroblasts. J Cell Sci 1984;66:51-63.
24. Baum CL, Arpey CJ. Normal cutaneous wound healing: clinical correlation with cellular and molecular events. Dermatol Surg 2005;31:674-686.
25. Monroe DM, Hoffman M, Roberts HR. Platelets and thrombin generation. Arterioscler Thromb Vasc Biol 2002;22:1381-1389.
26. Tiwari S, Italiano JE Jr, Barral DC, et al. A role for Rab27 in NF-E2-dependent pathways of platelet formation. Blood 2003;102:3970-3979.
27. Sehgal S, Storrie B. Evidence that differential packaging of the major platelet granule proteins von Willebrand factor and fibrinogen can support their differential release. J Thromb Haemost 2007;5:2009-2016.
28. Werner S, Grose R. Regulation of wound healing by growth factors and cytokines. Physiol Rev 2003;83:835-870.
29. Chow EK, O'Connell RM, Schilling S, et al. TLR agonists regulate PDGF-B production and cell proliferation through TGF-β/type IIFN crosstalk. EMBO J 2005;24:4071-4081.
30. Hinz B. Formation and function of the myofibroblast during tissue repair. J Invest Dermatol 2007;127:526-537.
31. Postlethwaite AE, Keski-Oja J, Balian G, et al. Induction of fibroblast chemotaxis by fibronectin. Localization of the chemotactic region to a 140,000-molecular weight non-gelatin binding fragment. J Exp Med 1981;153:494-499.
32. Xu J, Clark RA. Extracellular matrix alters PDGF regulation of fibroblast integrins. J Cell Biol 1996;132:239-249.
33. Ravanti L, Heino J, Lopez-Otin C, et al. Induction of collagenase-3 (MMP-13) expression in human skin fibroblasts by three-dimensional collagen is mediated by p38 mitrogen-activated protein kinase. J Biol Chem 1999;274:2446-2455.
34. Gabbiani G. Evolution and clinical implications for the myofibroblast concept. Cardiovasc Res 1998;38:545-548.
35. Sappino AP, Schurch W, Gabbiani G. Differentiation repertoire of fibroblastic cells: expression of cytoskeletal proteins as markers of phenotypic modulations. Lab Invest 1990;63:144-161.
36. Pan D, Zhe X, Jakkaraju S, et al. P311 induces a TGF-β1-independent, nonfibrogenic myofibroblast phenotype. J Clin Invest 2002;110:1349-1358.
37. Werb Z, Tremble P, Damsky CH, et al. Regulation of extracellular matrix degradation by cell-extracellular matrix interactions. Cell Differ Dev 1990;32:299-306.
38. Circolo A, Welgus HG, Pierce GF, et al. Differentiation regulation of the expression of proteinases/antiproteinases in fibroblasts. Effects of interleukin-1 and platelet-derived growth factor. J Biol Chem 1991;266:12283-12288.